Viz.ai announced clinical data validating the impact of the Viz LVO in the management and outcomes of patients with large ves ...

The CardioVascular Coalition (CVC) submitted official comments to the Centers for Medicare & Medicaid Services (CMS) on t ...

Quasar Medical announced the acquisition of Ridgeback Technologies, a Galway, Ireland–based developer of catheter ballo ...

Route 92 Medical, Inc. announced a new $50 million extension to its previously announced oversubscribed Series F financing, b ...

Synchron recently announced that a patient in the United States who had received the Synchron brain-computer interface (BCI) ...

Stryker announced that it has completed the acquisition of Nico Corporation, a privately held company providing a systematic ...

The Luxembourg-based vascular surgeon and breast oncology surgeon talks research priorities and innovation needs in dialysis ...

A new generation of catheters with a longer balloon, longer working length, and more pulses to manage calcified peripheral ...

Highlights and opportunities from CHAMPIONS, a program aimed at addressing disparities in vascular care in vascular deserts.

Figure 1. Treatment algorithm for CLTI and complex lesions. *IVL, intravascular lithotripsy.

Experts discuss differences in drug delivery between ATK and BTK, the future of sirolimus-coated balloons, device innovation in the infrapopliteal arteries, where drug-eluting bioresorbable scaffolds ...

Figure 1. Initial angiograms (A, B). A 2.5- X 80-mm Serranator PTA Serration Balloon for vessel preparation of the occluded PT artery prior to use of a bioresorbable scaffold (BRS) (C). Completion ...